Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies'
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies'
-
Narrado por:
-
De:
Acerca de esta escucha
Featuring an interview with Dr Jennifer Crombie, including the following topics:
- Overview of similarities and differences among CD20 x CD3 targeted bispecific antibodies for the treatment of lymphomas (0:00)
- Optimal integration of CD20 x CD3 bispecific antibodies into treatment algorithms for lymphomas (9:40)
- Case: A man in his late 60s with relapsed follicular lymphoma (FL) who received mosunetuzumab (23:52)
- Case: A man in his late 80s with transformed, double-hit diffuse large B-cell lymphoma (DLBCL) who received epcoritamab (28:46)
- Case: A woman in her early 70s with recurrent FL who received odronextamab on the ELM-1 trial (34:06)
- Case: A man in his early 80s with multiregimen-relapsed DLBCL who receives glofitamab (43:19)
CME information and select publications
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones